ConsultantLive Members: Login | Register
 |  |

 
SECTION EDITOR



Dr Rutecki is Professor of Medicine at the University of South Alabama College of Medicine in Mobile.


 
CLINICAL TRIALS
White Coat Hypertension and Antihypertensive Treatment Effect
www.clinicaltrials.gov -
Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.
www.clinicaltrials.gov -
Hypertension Education and Treatment Partnership for Reducing Ethnic Differences in the Risk of Cardiovascular Disease
www.clinicaltrials.gov -
 
NEWS
Hypertension
topics.searchmedica.com - 5/8/12
Gout
topics.searchmedica.com - 5/7/12
2012 regional coverage ... American Medical News
www.ama-assn.org - 5/7/12
 
PATIENT RESOURCES
Cardiomyopathy
ghr.nlm.nih.gov - 5/7/12
CARASIL
ghr.nlm.nih.gov - 5/7/12
CYP11B1
ghr.nlm.nih.gov - 5/7/12
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs
 
CONNECT WITH US
 Become a fan on
 Facebook
 Add us on
 Google Plus
 Follow us on
 Twitter
 Join our
 LinkedIn group
 Sign up for our
 Newsletters
 Subscribe to our
 RSS Feed

 
 
JOURNAL SCAN
ACCF/AHA/AMA-PCPI 2011 Performance Measures for Adults With Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for
content.onlinejacc.org - 5/15/12
Advertisement. Search. Still not a subscriber to JACC Imaging or JACC Interventions? J Am Coll Cardiol, 2012; 59: 1812-1832, doi: 10.1016/j.jacc.2012.03.013 ( Published online 23 April 2012). 2012 by the American College of Cardiology Foundation.
BMC Public Health | Abstract | Investigating maternal risk factors as potential targets of intervention to reduce socioeconomic inequality in small for gestational age: a population-based study
www.biomedcentral.com - 5/8/12
The major aim of this study was to investigate whether maternal risk factors associated with socioeconomic status and small for gestational age (SGA) might be viable targets of interventions to reduce differential risk of SGA by socioeconomic status (socioeconomic SGA inequality) in the metropolitan area of Vancouver, Canada.|The major aim of this study was to investigate whether maternal risk factors associated with socioeconomic status and small for gestational age (SGA) might be viable targets of interv
The management of neonatal pulmonary hypertension
fn.bmj.com - 5/1/12
Reviews. The management of neonatal pulmonary hypertension. ... Accepted 8 December 2010. Published Online First 30 January 2011. Most neonates with clinically significant pulmonary hypertension ( PH) will have either persistent PH of the newborn ( PPHN)
Sex Difference in Cardiovascular Risk: Role of Pulse Pressure Amplification
content.onlinejacc.org - 5/15/12
Background: Hypertension and CV complications are more severe in men and post-menopausal women than in pre-menopausal women. ... Key Words: cardiovascular risk sex hypertension pulse pressure pulse pressure amplification.
Update on the pathophysiology and management of idiopathic intracranial hypertension
jnnp.bmj.com - 5/1/12
Update on the pathophysiology and management of idiopathic intracranial hypertension. 1. ... Published Online First 15 March 2012. Idiopathic intracranial hypertension is a disease of unknown aetiology, typically affecting young obese women, producing a

Hypertension
 
WHAT'S NEW IN HYPERTENSION

When Medicine Isn’t Enough: Renal Sympathetic Denervation and Resistant Hypertension
April 10, 2012

What newer options are available to lower blood pressure in resistant hypertension? What about renal sympathetic denervation?

Doctors Beware: Certain Antihypertensives can Increase the Risk of Gout
February 15, 2012

Unfortunately, the growing epidemics of hypertension and gout are often a package deal. Recent data demonstrate that 74% of people with gout are also hypertensive.

Have We Been Measuring Blood Pressure Incorrectly All Along?
February 9, 2012

Yesterday, it all seemed so simple. Put a blood pressure cuff on the patient’s arm closest to you. Measure pressure once. Use the JNC guidelines and treat to target. But standard practice is getting a close second look. Why? Read details, here.

Controlling Blood Pressure in Chronic Renal Disease: Night Time is the Right Time
October 13, 2011

The authors’ opening salvo seems to say it all (again). . . “A patient’s nocturnal BP profile, without the pressor effect of physical activity, emotional stress, and environmental factors that are usually present during the day, is more representative of the true BP status and a stronger predictor of cardiovascular outcomes.”

Antihypertensives at Night: When You Snooze, You Lose?
September 14, 2011

Typically, antihypertensive medications are taken in the morning. But typically does not always equal correct! Preliminary studies have documented that a more appropriate approach would be to take them (or at least some of them) at bedtime.

Showing 1 - 5 of 12 results.
Page of 3
First Previous Last
 
LATEST FEATURES
May 17, 2011
Poll: Do you screen patients for high blood pressure and cholesterol?
A recent study found that women with gestational hypertension are not receiving appropriate follow-up care and prevention. Specifically, the researchers found that women with gestational hypertension were less likely to have their blood pressure checked within the previous 2 years and were less... More »
April 8, 2011
Ambulatory BP Helps Identify Resistant Hypertension
Ambulatory blood pressure monitoring is a useful prognosis tool to differentiate between true and white coat resistant hypertension, according to a study published online March 28 in Hypertension. More »
February 8, 2011
Lowering BP in Women Reduces Heart Disease Risk
High systolic blood pressure (BP) appears to be a substantial risk factor for cardiovascular events in women middle-aged and older, and many of these events are potentially preventable with lowered PB, according to research published online Jan 24 in Hypertension. More »
March 3, 2010
Treating Systolic Hypertension in the Elderly: How Low Should Diastolic BP Go?
What is the lowest acceptable diastolic blood pressure (BP) in an elderly patient who is being treated for systolic hypertension? More »
January 28, 2010
Lupus an independent risk factor for coronary artery disease
Women with systemic lupus erythematosus (SLE) are at increased risk for coronary artery disease (CAD) and mortality. The dominant risk factors are SLE itself, age, and high total triglyceride levels rather than the traditional Framingham risk factors. More »
March 1, 2008
Systolic Hypertension: A Guide to Optimal Therapy
Systolic hypertension is an independent risk factor for coronary artery disease, stroke, and end-stage renal disease. Nonpharmacological interventions for systolic hypertension include limitation of dietary sodium and alcohol intake along with weight reduction and aerobic exercise. More »
July 13, 2007
Hispanic Women Reap Greater Benefit From Blood Pressure Control
GAINESVILLE, Fla. -- Hispanic women with coronary artery disease and hypertension achieved better blood pressure control than non-Hispanic white counterparts who were treated with the same antihypertensive drugs. More »
May 1, 2007
Blood Pressure: What's Optimal? What's Not?
What is "normal" blood pressure (BP)? Is it different from optimal BP? More »
December 31, 2006
ACE Inhibitor + ARB = Effective Therapy?
Q:Do evidence-based data support combination therapy with an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin II receptor blocker (ARB)? More »
October 1, 2006
Diastolic Blood Pressure: How Low Can You Go?
What is the lowest acceptable diastolic blood pressure (DBP) in a patient with systolic hypertension who is older than 65 years? More »
Showing 1 - 10 of 15 results.
Page of 2
First Previous Last
 
RELATED ARTICLES

 
MEDLINE
Translational study of microRNAs and its application in kidney disease and hypertension research.
pubmed.gov - 5/1/12
MicroRNA research in humans and mammalian model organisms is in a crucial stage of development. Diagnostic and therapeutic values of microRNAs appear promising, but remain to be established. The physiological and pathophysiological significance of microRNAs is generally recognized, but much better understood in some organ systems and disease areas than others. In the present paper, we review several translational studies of microRNAs, including those showing the potential value of therapeutic agents targeting microRNAs and diagnostic or prognostic microRNA markers detectable in body fluids. We discuss the lessons learned and the experience gained from these studies. Several recent studies have begun to explore translational microRNA research in kidney disease and hypertension. Translational research of microRNAs in the kidney faces unique challenges, but provides many opportunities to develop and apply new methods, and to merge complementary basic and clinical approaches.
Young adults with SCD in US children's hospitals: are they different from adolescents?
pubmed.gov - 5/2/12
The period of transition from pediatric to adult care is a vulnerable time for patients with sickle cell disease (SCD). The optimal time for transition is unknown and there is no standard of care regarding this timing in the United States.|We collected administrative data from the Pediatric Health Information System for all SCD admissions from 2000 to 2009. We compared reasons for hospitalization and resulting charges in adolescents (13-17 years) and young adults (18-21 years).|We identified 25,371 admissions of adolescents (n = 18,299) and young adults (n = 7,072) with SCD. Median admissions per patient per year was higher in young adults (0.6) compared to adolescents (0.2, P < 0.001), but reasons for hospitalization were similar between the two age groups. Complications of adult SCD such as nephropathy and pulmonary hypertension were rare (<2.5% of discharges) but more frequent in older patients (P = 0.001). Although length of stay was similar between the two groups (median = 4 days)
Importance of monitoring renal function in patients with cancer.
pubmed.gov - 5/2/12
Monitoring renal function in patients with solid tumors and hematologic malignancies is vital to the safe administration of therapeutic agents. Renal impairment is frequent in elderly patients (i.e., age 65) with cancer, despite normal serum creatinine levels in most patients. Because serum creatinine levels do not accurately reflect clearance rates, renal function should be estimated by calculation (either Cockcroft-Gault or abbreviated Modification of Diet in Renal Disease [aMDRD] equations) or by measuring creatinine clearance using a 24-h urine collection. Additionally, patients with cancer often have preexisting comorbidities or other risk factors that increase the probability of renal impairment before receiving potentially nephrotoxic therapies. Patient age, preexisting renal dysfunction, and chronic comorbidities (e.g., diabetes, kidney disease, hypertension, and cardiac insufficiency) all contribute to the risk of renal impairment. Furthermore, both cancer and its
Life expectancy after treatment for systolic hypertension.
pubmed.gov - 4/4/12
22474193 2012 04 04 2012 04 05 1538-3598 307 13 Apr 4 JAMA 1368; author reply 1368-9 Coca Steven S eng Comment Letter United States JAMA 7501160 0098-7484 0 Antihypertensive Agents 77-36-1 Chlorthalidone AIM IM JAMA. 2011 Dec 21; 306( 23): 2588-93
Hypertension and end-stage renal disease: vital understanding needed.
pubmed.gov - 4/2/12
22137669 2012 03 19 2012 05 07 1097-6833 160 4 Apr J. Pediatr. 542-3 Narsipur Sriram S SS eng Comment Editorial 2011 12 03 United States J Pediatr 0375410 0022-3476 0 Antihypertensive Agents AIM IM J Pediatr. 2012 Apr; 160( 4): 621-625.e1 22056352
 
PRACTICE GUIDELINES
Current Clinical Practice Guidelines and Reports
www.nhlbi.nih.gov - 5/16/11
Contains NHLBI clinical guidelines for asthma, cholesterol and cholesterol screening, hypertension, and obesity.
Guide to Clinical Preventive Services, 2010-2011: Section 2 (continued)
www.ahrq.gov - 9/1/10
Reviews the evidence for and against hundreds of preventive health services, recommending tests, and counseling interventions when evidence exists that it is effective.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)
www.nhlbi.nih.gov - 12/20/10
Contains NHLBI clinical guidelines for asthma, cholesterol and cholesterol screening, hypertension, and obesity.



 
FROM PHYSICIANS PRACTICE
Physician Performance Goals Are Great, But Balance Is More Realistic
Jennifer Frank, MD,  May 15, 2012
Performance measurements for physicians are well-intentioned and get me to rethink how I practice. But in the end I won't make the goals, so I'll have to go with balance over perfection.
Designing the Perfect Business Card for Your Medical Practice
C. Noel Henley, MD,  May 11, 2012
Does your business card say anything substantive about the valuable work you do in your practice? Here’s how to re-design your next business card for maximum impact and engagement.
Registered Nurses an Ideal Fit for Primary Care Practices
Audrey "Christie" McLaughlin, RN,  May 10, 2012
Here are four good reasons to hire a registered nurse for your primary care practice …maybe even instead of a medical assistant.
The Five Biggest Medical Practice Marketing Mistakes
James Doulgeris,  May 10, 2012
There are best practices to marketing your practice, but often, success is more about knowing what not to do. Here are the five most common pitfalls …and how to avoid them.
Can You Practice Medicine and Manage Your Practice?
Rosemarie Nelson,  May 9, 2012
Whether you practice alone, or in a group, if you're trying to see patients in this pay-for-volume environment and also run the business of your practice, you may be missing out on important opportunities.
 
COMMENTS